GlaxoSmithKline ends aplaviroc trials
HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes
The real challenges for scaling up ART in sub-Saharan Africa
The HIV-1 clade C promoter is particularly well adapted to replication in the gut in primary infection
Thymic volume, T-cell populations, and parameters of thymopoiesis in adolescent and adult survivors of HIV infection acquired in infancy
Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol γ hypothesis
A nonsense mutation (428G→A) in the fucosyltransferase FUT2 gene affects the progression of HIV-1 infection
The independent effect of drug resistance on T cell activation in HIV infection
Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy
96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures
Enfuvirtide plasma levels and injection site reactions using a needle-free gas-powered injection system (Biojector)
Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108
Risk factors for HIV infection among men who have sex with men
Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion
The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model
Evolutionary history of HIV-1 subtype B and F infections in Brazil
A link between immune hyperactivation of T cells during HIV-1 infection and the virus protease?
Sympathetic nervous system function in HIV-associated adipose redistribution syndrome
Advanced immunosuppression at entry to HIV care in the southeastern United States and associated risk factors
Successful use of genotypic resistance testing in HIV-1-infected individuals with detectable viraemia between 50 and 1000 copies/ml
Point of care testing for antiretroviral therapy-related lactic acidosis in resource-poor settings
Tracing the origin of Brazilian HTLV-1 as determined by analysis of host and viral genes
Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir
Transient neuropathy after needle-free injection outside of recommended sites
Serum creatinine changes in HIV-seropositive patients receiving tenofovir
A rare HIV reverse transcriptase mutation, K65N, confers reduced susceptibility to tenofovir, lamivudine and didanosine
Controversy concerning role of ultrasonographic lipoatrophy assessments in HIV patients
Immune reconstitution: bad or good factor in hepatitis B virus and HIV co-infection?
Progressive multifocal leukoencephalopathy: prolonged survival in patients treated with protease inhibitors and cidofovir: a case series